IN8bio, Inc. (INAB)
USD 0.27
(-6.77%)
USD 0.27
(-6.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.34 Million | -24.12 Million | -13.5 Million | -7.13 Million | -4.8 Million | -2.76 Million |
| Net Income | -30 Million | -28.52 Million | -14.65 Million | -8.55 Million | -5.13 Million | -2.08 Million |
| Depreciation & Amortization | 2.5 Million | 1.1 Million | 788 Thousand | 88 Thousand | 96 Thousand | 96 Thousand |
| Deferred income taxes | 981 Thousand | -4.16 Million | -540.99 Thousand | - | - | - |
| Stock-based compensation | 4.37 Million | 3.46 Million | 2.19 Million | 357 Thousand | 76 Thousand | 31 Thousand |
| Change in working capital | -204 Thousand | -170 Thousand | -1.83 Million | 611 Thousand | 93 Thousand | -885 Thousand |
| Other non-cash items | -981 Thousand | 4.16 Million | 540.99 Thousand | 368 Thousand | 68 Thousand | 70 Thousand |
| Investing Cash Flow | -600 Thousand | -3.7 Million | -309 Thousand | - | 356 Thousand | -757 Thousand |
| Investments in PPE | -600 Thousand | -3.7 Million | -309 Thousand | - | -330 Thousand | -757 Thousand |
| Acquisitions | - | - | - | - | 686 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -195 Thousand | -16 Thousand | -309 Thousand | - | 686.00 | - |
| Financing Cash Flow | 27.04 Million | 8.98 Million | 32.95 Million | 24.51 Million | 65 Thousand | 8.5 Million |
| Debt repayment | -798 Thousand | -615 Thousand | -709 Thousand | -174 Thousand | - | -803 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 27.84 Million | 9.54 Million | 36.32 Million | 499 Thousand | 65 Thousand | 7.23 Million |
| Other Financing Activities | 17.65 Million | 61 Thousand | -2.66 Million | 24.19 Million | 65.00 | 9.3 Million |
| Accounts receivables | - | - | - | - | 30 Thousand | -30 Thousand |
| Accounts payables | -981 Thousand | 1.51 Million | -319 Thousand | -160 Thousand | 141 Thousand | -152 Thousand |
| Inventory | - | - | - | - | -30 Thousand | - |
| Other working capital | 777 Thousand | -1.68 Million | -1.52 Million | 771 Thousand | -48 Thousand | -733 Thousand |
| Cash at beginning of period | 18.18 Million | 37.27 Million | 18.13 Million | 610 Thousand | 4.99 Million | 15 Thousand |
| Cash at end of period | 21.28 Million | 18.43 Million | 37.27 Million | 17.99 Million | 610 Thousand | 4.99 Million |
| Capital Expenditure | -600 Thousand | -3.7 Million | -309 Thousand | - | -330 Thousand | -757 Thousand |
| Effect of forex changes on cash | -4000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 3.1 Million | -18.83 Million | 19.13 Million | 17.38 Million | -4.38 Million | 4.97 Million |
| Free Cash Flow | -23.94 Million | -27.82 Million | -13.81 Million | -7.13 Million | -5.13 Million | -3.52 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.62 Million | -8.56 Million | -30 Million | -7.59 Million | -7.16 Million | -7.71 Million |
| Depreciation & Amortization | 631 Thousand | 632 Thousand | 2.5 Million | 627 Thousand | 647 Thousand | 637 Thousand |
| Deferred income taxes | - | - | 981 Thousand | -2.3 Million | -7.16 Million | 1.01 Million |
| Stock-based compensation | 1.17 Million | 1.24 Million | 4.37 Million | 1.25 Million | 1.24 Million | 1.01 Million |
| Change in working capital | 736 Thousand | -1.22 Million | -204 Thousand | 869 Thousand | -431 Thousand | 721 Thousand |
| Other non-cash items | 2.4 Million | 1729.00 | -981 Thousand | 2.3 Million | 7.16 Million | -1.01 Million |
| Investing Cash Flow | -83 Thousand | -71 Thousand | -600 Thousand | -72 Thousand | -77 Thousand | -22 Thousand |
| Investments in PPE | -83 Thousand | -71 Thousand | -600 Thousand | -72 Thousand | -77 Thousand | -22 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -21 Thousand | -195 Thousand | -195 Thousand | - | - |
| Financing Cash Flow | 3.37 Million | -277 Thousand | 27.04 Million | 13.35 Million | 1.65 Million | 11.49 Million |
| Debt repayment | -174 Thousand | -188 Thousand | -798 Thousand | -173 Thousand | -236 Thousand | -214 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 8.58 Billion | - | - | - | - | - |
| Common Stock Issuance | 3.55 Million | -89 Thousand | 27.84 Million | 13.52 Million | 1.88 Million | 11.7 Million |
| Other Financing Activities | 3553.00 | -89 Thousand | 17.65 Million | 13.52 Thousand | 1888.00 | 11.49 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 29 Thousand | 489 Thousand | -981 Thousand | 200 Thousand | 209 Thousand | -355 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 707 Thousand | -1718.00 | 777 Thousand | 669 Thousand | -640 Thousand | 1.07 Million |
| Cash at beginning of period | 13.01 Million | 21.53 Million | 18.18 Million | 12.85 Million | 17.24 Million | 11.11 Million |
| Cash at end of period | 10.21 Million | 13.27 Million | 21.28 Million | 21.28 Million | 13.1 Million | 17.24 Million |
| Capital Expenditure | -83 Thousand | -71 Thousand | -600 Thousand | -72 Thousand | -77 Thousand | -22 Thousand |
| Effect of forex changes on cash | - | - | -4000.00 | -2000.00 | -3.03 Million | -5.11 Million |
| Net cash flow / Change in cash | -2.79 Million | -8.26 Million | 3.1 Million | 8.42 Million | -4.13 Million | 6.13 Million |
| Free Cash Flow | -6.17 Million | -7.99 Million | -23.94 Million | -4.92 Million | -5.79 Million | -5.36 Million |
ECL
LILAK
HIMX
SAPL
002724
ASQ